Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancerRenaming "chemobrain"Brain estrogens rapidly strengthen auditory encoding and guide song preference in a songbird.Brain sex matters: estrogen in cognition and Alzheimer's diseaseWhat do perceived cognitive problems reflect?Status of adjuvant endocrine therapy for breast cancer.Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.Cognitive Effects of Systemic Therapy in Patients with Breast CancerCognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.Do aromatase inhibitors have adverse effects on cognitive function?Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapyClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsPsychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial.Breast cancer medications and vision: effects of treatments for early-stage disease.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatmentA 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.Patterns of change in cognitive function with anastrozole therapy.Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.Safety of aromatase inhibitors in the adjuvant setting.Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline.Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.Cognitive functioning and aging in women.Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?Cognitive functioning in breast cancer survivors: a controlled comparison.Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a reviewBreast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.Prevention of breast cancer (Part II): risk reduction strategies.Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.Clearing the air: a review of our current understanding of "chemo fog".Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
P2860
Q21146752-A4CAB436-2A66-48D0-B990-4DE0ACD3C953Q24634011-0D727184-D58E-44D1-8EE4-A9893F0C6699Q28249848-30D7F4C6-966B-4A7C-9A22-3C9B3C238CF2Q30479918-66AA7A2D-0235-408D-867B-54C6AC5E838AQ33693268-2F4B4C00-783F-46EF-8E3D-427142FB6786Q33707551-0832A2DA-CC0B-49C7-95A8-C0E7BA15CD04Q33739138-2331C348-283B-4AD0-A557-7B1B0E2C05ECQ33841626-6688D5BD-2BDD-49C2-B038-5860B29988E4Q33921226-230F8B38-6331-462C-A15A-09AE28311E2BQ34065038-4808A9D4-51EA-4138-BDE0-024F7A2A7B87Q34095832-4FD6E367-583E-4DD5-B1FB-F46C57A83678Q34402534-B023960D-C526-45C2-B1D6-0B586019BB34Q34604179-E6174004-71AA-4AF3-936F-D0831DAF85EBQ35029513-0441297F-78BE-4C61-8732-B0CC1B2D2D60Q35116057-5CBFAA96-CE03-4BB7-B3D8-D2BDEDFD5E30Q35164117-8C83A6A3-DA56-4241-958A-EA1C8DDECC17Q35215913-A76401B7-82DA-4361-90DC-EFB9DDB18B77Q35496778-F004EBE0-CF96-476B-A87D-2B39FCF00218Q35535907-CEBFAF64-E8C9-428A-AFEA-1EE08C878949Q35551034-8A1D0441-4960-45AB-814A-0879D744B966Q35851810-D37E14E5-DF89-4405-A7FB-568887807337Q35883135-BA9F3E5F-B4D4-4D3A-B677-330736E49F24Q35949546-DBEE379C-D0E7-41E5-BBD1-CF88202795ECQ36026543-06F9301E-059D-4F73-85CD-CC8517B1C6D9Q36106017-679C97E0-E23F-4FCF-89D2-15D84E56374EQ36528154-8342B54C-4B4F-41D7-BBB9-FBE4EB0CE145Q36684067-4A627073-6441-4937-A79D-D251A93FD745Q36858541-3BC1249D-102A-4FE9-853E-96746D40FEE9Q36901307-80446CDD-1921-43CF-AD99-6D3A1C348147Q37147787-656049B5-F50C-4B62-9349-5714C52BF6BAQ37157773-9BABE216-B79E-4DE2-B218-9F7FC1CD837AQ37354647-A9B64631-B7CC-46E8-B073-42BCFAD930EFQ37585300-8EB9D5E7-99DF-4693-BD21-FA6099A4FFDDQ37798835-F14C57FC-75ED-4E14-8BDF-C776608A5DC6Q37830371-E37FF63B-FF48-441C-B96B-0C9F157ABDF2Q37931900-AEA4894B-0BAD-435F-A581-51A3712D3CD0Q37976412-0681E176-F8C1-4E6B-A436-70C175126C78Q38088668-0B230390-EA74-4703-8312-253A52A26946Q38385116-F65F576E-C3DA-489F-BB7C-A363635C3339Q38551397-6ADA2C0D-CDB3-4DD2-9681-245D65E860E3
P2860
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Does hormone therapy for the t ...... and cognition? A pilot study.
@en
Does hormone therapy for the t ...... and cognition? A pilot study.
@nl
type
label
Does hormone therapy for the t ...... and cognition? A pilot study.
@en
Does hormone therapy for the t ...... and cognition? A pilot study.
@nl
prefLabel
Does hormone therapy for the t ...... and cognition? A pilot study.
@en
Does hormone therapy for the t ...... and cognition? A pilot study.
@nl
P2093
P50
P356
P1433
P1476
Does hormone therapy for the t ...... and cognition? A pilot study.
@en
P2093
Sam Hutton
Valerie Jenkins
Valerie Shilling
P356
10.1002/PON.709
P577
2004-01-01T00:00:00Z